TransMedics Group's market cap is currently ―. The company's EPS TTM is $-0.34; its P/E ratio is -405.11; TransMedics Group is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 96.85M	$ 81.17M	$ 66.43M	$ 52.47M	$ 41.55M
Gross Profit	$ 59.96M	$ 78.58M	$ 40.66M	$ 52.47M	$ 28.77M
EBIT	$ 12.42M	$ 7.47M	$ -23.34M	$ 1.52M	$ -1.53M
EBITDA	$ 16.72M	$ 11.07M	$ -21.45M	$ 2.92M	$ -247.00K
Net Income Common Stockholders	$ 12.20M	$ 4.03M	$ 29.00M	$ -1.00M	$ -2.64M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 350.20M	$ 394.80M	$ 427.10M	$ 582.20M	$ 195.40M
Total Assets	$ 723.83M	$ 706.05M	$ 689.23M	$ 690.35M	$ 287.09M
Total Debt	$ 516.22M	$ 515.95M	$ 515.65M	$ 515.01M	$ 67.31M
Net Debt	$ 166.02M	$ 121.15M	$ 88.55M	$ -67.19M	$ -128.09M
Total Liabilities	$ 564.36M	$ 568.85M	$ 562.77M	$ 545.14M	$ 94.46M
Stockholders Equity	$ 159.47M	$ 137.20M	$ 126.46M	$ 145.23M	$ 192.63M
Cash Flow	-
Free Cash Flow	$ -47.61M	$ -33.51M	$ -114.59M	$ -7.18M	$ -9.59M
Operating Cash Flow	$ -3.44M	$ 8.30M	$ -6.87M	$ -5.80M	$ -8.66M
Investing Cash Flow	$ -44.17M	$ -41.82M	$ -149.83M	$ -1.38M	$ -927.00K
Financing Cash Flow	$ 3.19M	$ 924.00K	$ 1.52M	$ 394.01M	$ 3.96M

Currency in USD

TransMedics Group Earnings and Revenue History

Income Statement >

TransMedics Group Debt to Assets

Balance Sheet >

TransMedics Group Cash Flow

Cash Flow >

TransMedics Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing